Genetic variation in dopaminergic activity is associated with the risk for psychiatric side effects of levetiracetam

Epilepsia

Volumn 54, Issue 1, 2013, Pages 36-44

  Helmstaedter, Christoph ^a,c   Mihov, Yoan ^a   Toliat, Mohammad R ^b   Thiele, Holger ^b   Nuernberg, Peter ^b   Schoch, Susanne ^a   Surges, Rainer ^a   Elger, Christian E ^a   Kunz, Wolfram S ^a   Hurlemann, René ^a  

^a UNIVERSITY OF BONN   (Germany)

^b UNIVERSITY OF COLOGNE   (Germany)

^c UNIVERSITY HOSPITAL BONN   (Germany)

Author keywords

Aggression; Dopamine; Levetiracetam; Pharmacognetics; Vulnerability

Indexed keywords

CARBAMAZEPINE; CATECHOL METHYLTRANSFERASE; CLOBAZAM; CLONAZEPAM; DOPAMINE 2 RECEPTOR; DOPAMINE BETA MONOOXYGENASE; ESLICARBAZEPINE ACETATE; ETIRACETAM; GABAPENTIN; LAMOTRIGINE; OXCARBAZEPINE; PHENOBARBITAL; PHENYTOIN; PREGABALIN; PRIMIDONE; TOPIRAMATE; VALPROIC ACID; ZONISAMIDE;

ADULT; AGGRESSION; ARTICLE; BEHAVIOR CHANGE; DNA POLYMORPHISM; DOPAMINERGIC ACTIVITY; DRUG EFFECT; EPILEPSY; FEMALE; GENETIC VARIABILITY; HUMAN; IMPULSIVENESS; IRRITABILITY; MAJOR CLINICAL STUDY; MALE; META ANALYSIS (TOPIC); PRIORITY JOURNAL; RISK ASSESSMENT; SIDE EFFECT;

ADULT; AGGRESSION; ANTICONVULSANTS; CATECHOL O-METHYLTRANSFERASE; DOPAMINE; DOPAMINE BETA-HYDROXYLASE; EPILEPSY; FEMALE; GENETIC PREDISPOSITION TO DISEASE; HUMANS; IRRITABLE MOOD; MALE; PIRACETAM; POLYMORPHISM, SINGLE NUCLEOTIDE; PSYCHIATRIC STATUS RATING SCALES; RECEPTORS, DOPAMINE D2; RISK FACTORS;

EID: 84872095204     PISSN: 00139580     EISSN: 15281167     Source Type: Journal    
DOI: 10.1111/j.1528-1167.2012.03603.x     Document Type: Article

References (43)

1. Abou-Khalil B,. (2005) Benefit-risk assessment of levetiracetam in the treatment of partial seizures. Drug Saf 28: 871-890.
2. Ben-Menachem E, Falter U,. (2000) Efficacy and tolerability of levetiracetam 3000 mg/d in patients with refractory partial seizures: a multicenter, double-blind, responder-selected study evaluating monotherapy. European Levetiracetam Study Group. Epilepsia 41: 1276-1283.
3. Berkovic S, Knowlton R, Leroy R, Schiemann J, Falter U,. (2007) Placebo-controlled study of levetiracetam in idiopathic generalized epilepsy. Neurology 69: 1751-1760.
4. Brunner H, Nelen M, Breakefield X, Ropers H, van Oost B,. (1993) Abnormal behavior associated with a point mutation in the structural gene for Monoamine Oxidase A. Science 262: 5578-5580.
5. Cases O, Seif I, Grimsby J, Gaspar P, Chen K, Pournin S, Müller U, Aguet M, Babinet C, Shih J, Maeyer E,. (1995) Aggressive behavior and altered amounts of brain serotonin and norepinephrine in mice lacking MAOA. Science 268: 1763-1766.
6. Caspi A, Langley K, Milne B, Moffitt TE, O'Donovan M, Owen MJ, Polo Tomas M, Poulton R, Rutter M, Taylor A, Williams B, Thapar A,. (2008) A replicated molecular genetic basis for subtyping antisocial behavior in children with attention-deficit/hyperactivity disorder. Arch Gen Psychiatry 65: 203-210.
7. Comings D, Comings B, Muhleman D, Dietz G, Shahbahrami B, Tast D, Knell E, Kocsis P, Baumgarten R, Kovacs B, Levy D, Smith M, Borison R, Evans D, Klein D, MacMurray J, Tosk J, Sverd J, Gysin R, Flanagan S,. (1991) The dopamine D2 receptor locus as a modifying gene in neuropsychiatric disorders. JAMA 266: 1793-1800.
8. Cordell H, Clayton D,. (2005) Genetic association studies. Lancet 366: 1211-1311.
9. Craig I, Halton K,. (2009) Genetics of human aggressive behaviour. Hum Genet 126: 101-113.
10. Dinkelacker V, Dietl T, Widman G, Lengler U, Elger C,. (2003) Aggressive behavior of epilepsy patients in the course of levetiracetam add-on therapy: report of 33 mild to severe cases. Epilepsy Behav 4: 537-547.
11. Domschke K, Sheehan K, Lowe N, Kirley A, Mullins C, O'Sullivan R, Freitag C, Becker T, Conroy J, Fitzgerald M, Gill M, Hawi Z,. (2005) Association analysis of the Monoamine Oxidase A and B genes with Attention Deficit Hyperactivity Disorder (ADHD) in an Irish sample: preferential transmission of the MAO-A 941G allele to affected children. Am J Med Genet B Neuropsychiatr Genet 134B: 110-114.
12. Eisenberg J, Mei-Tal G, Steinberg A, Tartakovsky E, Zohar A, Gritsenko I, Nemanov L, Ebstein R,. (1999) Haplotype relative risk study of Catechol-O-Methyltransferase (COMT) and Attention Deficit Hyperactivity Disorder (ADHD): association of the high-enzyme activity Val allele with ADHD impulsive-hyperactive phenotype. Am J Med Genet B Neuropsychiatr Genet 88: 497-502.
13. French J, Pedley T,. (2008) Initial management of epilepsy. N Engl J Med 359: 166-176.
14. Giegling I, Hartmann A, Möller H, Rujescu D,. (2006) Anger- and aggression-related traits are associated with polymorphisms in the 5-HT-2A gene. J Affect Disord 96: 75-81.
15. Gogos J, Morgan M, Luine V, Santha M, Ogawa S, Pfaff D, Karayiorgou M,. (1998) Catechol-O-methyltransferase-deficient mice exhibit sexually dimorphic changes in catecholamine levels and behavior. Proc Natl Acad Sci USA 95: 9991-9996.
16. Helmstaedter C, Fritz NE, Kockelmann E, Kosanetzky N, Elger CE,. (2008) Positive and negative psychotropic effects of levetiracetam. Epilepsy Behav 13: 535-541.
17. Hennig J, Reuter M, Netter P, Burk C, Landt O,. (2005) Two types of aggression are differentially related to serotonergic activity and the A779C TPH polymorphism. Behav Neurosci 119: 16-25.
18. Hess C, Reif A, Strobel A, Boreatti-Hümmer A, Heine M, Lesch K, Jacob C,. (2009) A functional dopamine-beta-hydroxylase gene promoter polymorphism is associated with impulsive personality styles, but not with affective disorders. J Neural Transm 116: 121-130.
19. Kazantseva A, Gaysina D, Malykh S, Khusnutdinova E,. (2011) The role of dopamine transporter (SLC6A3) and dopamine D2 receptor/ankyrin repeat and kinase domain containing 1 (DRD2/ANKK1) gene polymorphisms in personality traits. Prog Neuropsychopharmacol Biol Psychiatry 35: 1033-1040.
20. Kestler L, Malhotra A, Finch C, Adler C, Breier A,. (2000) The relation between dopamine D2 receptor density and personality: preliminary evidence from the NEO personality inventory-revised. Neuropsychiatry Neuropsychol Behav Neurol 13: 48-52.
21. Kim C, Hahn M, Joung Y, Anderson S, Steele A, Mazei-Robinson M, Gizer I, Teicher M, Cohen B, Robertson D, Waldman I, Blakely R, Kim K,. (2006) A polymorphism in the norepinephrine transporter gene alters promoter activity and is associated with attention-deficit hyperactivity disorder. Proc Natl Acad Sci USA 103: 19164-19169.
22. Kirley A, Hawi Z, Daly G, McCarron M, Mullins C, Millar N, Waldman I, Fitzgerald M, Gill M,. (2002) Dopaminergic system genes in ADHD: toward a biological hypothesis. Neuropsychopharmacology 27: 607-619.
23. Lo BW, Kyu HH, Jichici D, Upton AM, Akl EA, Meade MO,. (2011) Meta-analysis of randomized trials on first line and adjunctive levetiracetam. Can J Neurol Sci 38: 475-486.
24. Lynch JM, Tate SK, Kinirons P, Weale ME, Cavalleri GL, Depondt C, Murphy K, O'Rourke D, Doherty CP, Shianna KV, Wood NW, Sander JW, Delanty N, Goldstein DB, Sisodiya SM,. (2009) No major role of common SV2A variation for predisposition or levetiracetam response in epilepsy. Epilepsy Res 83: 44-51.
25. Lyseng-Williamson KA,. (2011) Levetiracetam: a review of its use in epilepsy. Drugs 71: 489-514.
26. Manuck S, Flory J, Ferrell R, Dent K, Mann J, Muldoon M,. (1999) Aggression and anger-related traits associated with a polymorphism of the tryptophan hydroxylase gene. Biol Psychiatry 45: 603-614.
27. McCormack M, Alfirevic A, Bourgeois S, Farrell J, Kasperavič iūtė D, Carrington M, Sills G, Marson T, Jia X, de Bakker P, Chinthapalli K, Molokhia M, Johnson M, O'Connor G, Chaila E, Alhusaini S, Shianna K, Radtke R, Heinzen E, Walley N, Pandolfo M, Pichler W, Park B, Depondt C, Sisodiya S, Goldstein D, Deloukas P, Delanty N, Cavalleri G, Pirmohamed M,. (2011) HLA-A 3101 and carbamazepine-induced hypersensitivity reactions in europeans. N Engl J Med 364: 1134-1143.
28. Miller S, Dykes D, Polesky H,. (1988) A simple salting out procedure for extracting DNA from human nucleated cells. Nucleic Acids Res 16: 1215.
29. Munafo M, Matheson I, Flint J,. (2007) Association of the DRD2 gene Taq1A polymorphism and alcoholism: a meta-analysis of case-control studies and evidence of publication bias. Mol Psychiatry 12: 454-461.
30. Munafo M, Timpson N, David S, Ebrahim S, Lawlor D,. (2009) Association of the DRD2 gene Tag1A polymorphism and smoking behavior: a meta-analysis and new data. Nicotine Tob Res 11: 64-76.
31. Nobile M, Rusconi M, Bellina M, Marino C, Giorda R, Carlet O, Vanzin L, Molteni M, Battaglia M,. (2010) COMT Val158Met polymorphism and socioeconomic status interact to predict attention deficit/hyperactivity problems in children aged 10-14. Eur Child Adolesc Psychiatry 19: 549-557.
32. Ritchie T, Noble E,. (2003) Association of seven polymorphisms of the D2 dopamine receptor gene with brain receptor-binding characteristics. Neurochem Res 28: 73-82.
33. Rogeness G, Hernandez J, Macedo C, Mitchell EL,. (1982) Biochemical differences in children with conduct disorder socialized and undersocialized. Am J Psychiatry 139: 307-311.
34. Rosenthal R, Rubin D,. (1982) A simple, general purpose display of magnitude of experimental effect. J Educ Psychol 74: 166-169.
35. Skol A, Scott L, Abecasis G, Boehnke M,. (2006) Joint analysis is more efficient than replication-based analysis for two-stage genome-wide association studies. Nat Genet 38: 209-213.
36. Sole X, Guino E, Valls J, Iniesta R, Moreno V,. (2006) SNPStats: a web tool for the analysis of association studies. Bioinformatics 22: 1928-1929.
37. Soyka M, Preuss U, Koller G, Zill P, Bondy B,. (2004) Association of 5-HT1B receptor gene and antisocial behavior in alcoholism. J Neural Transm 111: 101-109.
38. Stelzel C, Basten U, Montag C, Reuter M, Fiebach C,. (2010) Frontostriatal involvement in task switching depends on genetic differences in d2 receptor density. J Neurosci 30: 14205-14212.
39. Surges R, Volynski K, Walker M,. (2008) Is levetiracetam different from other antiepileptic drugs? Levetiracetam and its cellular mechanism of action in epilepsy revisited Ther Adv Neurol Disord 1: 13-24.
40. Terracciano A, Tanaka T, Sutin A, Sanna S, Deiana B, Lai S, Uda M, Schlessinger D, Abecasis G, Ferrucci L, Costa P,. (2010) Genome-wide association scan of trait depression. Biol Psychiatry 68: 811-817.
41. Xu X, Brookes K, Chen C, Huang Y, Wu Y, Asherson P,. (2007) Association study between the monoamine oxidase A gene and attention deficit hyperactivity disorder in Taiwanese samples. BMC Psychiatry 7: 10. doi:10.1186/1471-244X-7-10.
42. Zai C, Ehtesham S, Choi E, Nowrouzi B, de Luca V, Stankovich L, Davidge K, Freeman N, King N, Kennedy J, Beitchman J,. (2011) Dopaminergic system genes in childhood aggression: possible role for DRD2. World J Biol Psychiatry 3: 65-74.
43. Zhang H, Wang Y, Li J, Wang B, Yang L,. (2005) Association between dopamine beta hydroxylase gene and attention deficit hyperactivity disorder complicated with disruptive behavior disorder. Zhonghua Er Ke Za Zhi 43: 26-30.